Evidence map›Paper›PMID 33211942›Full record

ArticleCancer research and treatment2021

Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry.

Hyeong In Ha, Eun-Gyeong Lee, Jiwon Lim, So-Youn Jung, Yoon Jung Chang, Young-Joo Won, Myong Cheol Lim

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer research and treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Hyeong In HaCenter for Gynecologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Eun-Gyeong LeeCenter for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Jiwon LimDivision of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Korea.
So-Youn JungCenter for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Yoon Jung ChangDivision of Cancer Control and Policy, National Cancer Control Institute, National Cancer Center, Goyang, Korea.
Young-Joo WonDivision of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Korea.
Myong Cheol LimCenter for Gynecologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
National Cancer Center · KRNational Cancer Center · US

Funding

National Cancer Center 1910132National Cancer Center 1911274
6 · The paper itself

Abstract

purposeA prior history of breast cancer is a risk factor for the subsequent development of primary peritoneal, epithelial ovarian, and fallopian tubal (POFT) cancers. This study aimed to estimate the incidence of secondary POFT malignancy in breast cancer patients and the clinical outcomes of primary and secondary POFT cancer. MATERIALS AND

methodsWe searched the Korea Central Cancer Registry to find patients with primary and secondary POFT cancer who had breast cancer in 1999-2017. The incidence rate and standardized incidence ratio were calculated. Additionally, we compared the overall survival of patients with primary and secondary POFT cancer.

resultsBased on the age-standardized rate, the incidence of second primary POFT cancer after breast cancer was 0.0763 per 100,000 women, which increased in Korea between 1999 and 2017. Among the 30,366 POFT cancer patients, 25,721 were primary POFT cancer only, and 493 had secondary POFT cancer after a breast cancer diagnosis. Second primary POFT cancer patients were older at the time of diagnosis (55 vs. 53, p < 0.001) and had a larger proportion of serous histology (68.4% vs. 51.2%, p < 0.001) than patients with primary POFT. There were no differences between the two groups in tumor stage at diagnosis. The 5-year overall survival rates were 60.2% and 56.3% for primary and secondary POFT cancer, respectively (p=0.216).

conclusionThe incidence of second primary POFT cancer after breast cancer increased in Korea between 1999 and 2017. Besides, second primary POFT cancer patients were diagnosed at older ages and had more serous histology.

Indexed as

AdultAgedAged, 80 and overBreast NeoplasmsFallopian Tube NeoplasmsFemaleHumansMiddle AgedNeoplasms, Second PrimaryOvarian NeoplasmsPeritoneal NeoplasmsRegistriesRepublic of KoreaSurvival RateBreast neoplasmsEpithelial ovarian cancerFallopian tube neoplasmsOvarian neoplasmsPrimary peritonealSecond primary neoplasms

Identifiers

PMID33211942
PMCPMC8053875
OpenAlexW3099933838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.